Activation of Beta 2 Adrenergic Receptor in Osteoblasts Contributes to Bone Metastasis Progression via IL-6-dependent Upregulation of Myeloid-Derived Suppressor Cells
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Lee, Eun Jung | - |
dc.contributor.author | Yun, Da Hyeon | - |
dc.contributor.author | Park, Serk In | - |
dc.date.accessioned | 2022-08-14T09:41:24Z | - |
dc.date.available | 2022-08-14T09:41:24Z | - |
dc.date.created | 2022-08-12 | - |
dc.date.issued | 2022-02 | - |
dc.identifier.issn | 0884-0431 | - |
dc.identifier.uri | https://scholar.korea.ac.kr/handle/2021.sw.korea/143137 | - |
dc.language | English | - |
dc.language.iso | en | - |
dc.publisher | WILEY | - |
dc.title | Activation of Beta 2 Adrenergic Receptor in Osteoblasts Contributes to Bone Metastasis Progression via IL-6-dependent Upregulation of Myeloid-Derived Suppressor Cells | - |
dc.type | Article | - |
dc.contributor.affiliatedAuthor | Park, Serk In | - |
dc.identifier.wosid | 000778074501152 | - |
dc.identifier.bibliographicCitation | JOURNAL OF BONE AND MINERAL RESEARCH, v.37, pp.240 - 240 | - |
dc.relation.isPartOf | JOURNAL OF BONE AND MINERAL RESEARCH | - |
dc.citation.title | JOURNAL OF BONE AND MINERAL RESEARCH | - |
dc.citation.volume | 37 | - |
dc.citation.startPage | 240 | - |
dc.citation.endPage | 240 | - |
dc.type.rims | ART | - |
dc.type.docType | Meeting Abstract | - |
dc.description.journalClass | 1 | - |
dc.description.journalRegisteredClass | scie | - |
dc.description.journalRegisteredClass | scopus | - |
dc.relation.journalResearchArea | Endocrinology & Metabolism | - |
dc.relation.journalWebOfScienceCategory | Endocrinology & Metabolism | - |
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.
(02841) 서울특별시 성북구 안암로 14502-3290-1114
COPYRIGHT © 2021 Korea University. All Rights Reserved.
Certain data included herein are derived from the © Web of Science of Clarivate Analytics. All rights reserved.
You may not copy or re-distribute this material in whole or in part without the prior written consent of Clarivate Analytics.